(Q36305776)

13 August 2017

1 reference

title

Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders (English)

1 reference

Other pervasive developmental disorders

13 August 2017

0 references

0 references

1 reference

1 reference

Richard P Malone

1

1 reference

13 August 2017

Silvia S Gratz

series ordinal

2

1 reference

13 August 2017

Mary Anne Delaney

series ordinal

3

1 reference

13 August 2017

Susan B Hyman

series ordinal

4

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

19

1 reference

13 August 2017

11

1 reference

13 August 2017

923-934

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200519110-00003

13 August 2017

0 references

cites work

Naltrexone in autistic children: an acute open dose range tolerance trial

1 reference

12 December 2020

Growth and sexual maturation during long-term treatment with risperidone

1 reference

12 December 2020

Levodopa and levoamphetamine: a crossover study in young schizophrenic children

1 reference

12 December 2020

Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial

1 reference

12 December 2020

Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases.

1 reference

12 December 2020

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study

1 reference

12 December 2020

Open trial of risperidone in 24 young children with pervasive developmental disorders.

1 reference

12 December 2020

Oxytocin, vasopressin, and autism: is there a connection?

1 reference

12 December 2020

Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism

1 reference

12 December 2020

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

1 reference

12 December 2020

Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour

1 reference

12 December 2020

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

1 reference

12 December 2020

Improved social and language skills after secretin administration in patients with autistic spectrum disorders

1 reference

12 December 2020

A pilot study of clomipramine in young autistic children.

1 reference

12 December 2020

A retrospective open trial of adjunctive donepezil in children and adolescents with autistic disorder

1 reference

12 December 2020

A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism

1 reference

12 December 2020

The effect of high doses of vitamin B6 on autistic children: a double- blind crossover study

1 reference

12 December 2020

A Comparison of Haloperidol and Behavior Therapy and Their Interaction in Autistic Children

1 reference

12 December 2020

Risperidone in young children with pervasive developmental disorders and other developmental disabilities.

1 reference

12 December 2020

Fluoxetine Treatment of Children and Adults with Autistic Disorder and Mental Retardation

1 reference

12 December 2020

Case study: risperidone treatment of children and adolescents with developmental disorders.

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

1 reference

12 December 2020

Open-label quetiapine in the treatment of children and adolescents with autistic disorder.

1 reference

12 December 2020

Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness

1 reference

12 December 2020

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study.

1 reference

12 December 2020

Novel antipsychotic medications in the treatment of children and adolescents

1 reference

12 December 2020

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

1 reference

12 December 2020

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism

1 reference

12 December 2020

Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report

1 reference

12 December 2020

Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.

1 reference

12 December 2020

Treatment of autistic disorder

1 reference

12 December 2020

Naltrexone in autistic children: behavioral symptoms and attentional learning

1 reference

12 December 2020

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

12 December 2020

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children

1 reference

12 December 2020

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

1 reference

12 December 2020

Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism

1 reference

12 December 2020

Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

1 reference

12 December 2020

Low-dose naltrexone effects on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Use of risperidone in pervasive developmental disorders: a case series.

1 reference

12 December 2020

Clinical effects of clozapine on autistic disorder.

1 reference

12 December 2020

Behavioral effects of haloperidol in young autistic children. An objective analysis using a within-subjects reversal design.

1 reference

12 December 2020

Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial

1 reference

12 December 2020

Fluoxetine response in children with autistic spectrum disorders: correlation with familial major affective disorder and intellectual achievement

1 reference

12 December 2020

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

12 December 2020

Olanzapine versus haloperidol in children with autistic disorder: an open pilot study

1 reference

12 December 2020

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

1 reference

12 December 2020

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

1 reference

12 December 2020

Quetiapine in nine youths with autistic disorder

1 reference

12 December 2020

Case series: use of ziprasidone for maladaptive symptoms in youths with autism

1 reference

12 December 2020

A multi-center double-blind trial of pimozide (Orap), haloperidol and placebo in children with behavioral disorders, using crossover design

1 reference

12 December 2020

Treatment of ADHD in children with tics: a randomized controlled trial

1 reference

12 December 2020

Secretin for the treatment of autism

1 reference

12 December 2020

Secretin and autism: a two-part clinical investigation

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

1 reference

12 December 2020

A retrospective assessment of citalopram in children and adolescents with pervasive developmental disorders

1 reference

12 December 2020

A five to fifteen year follow-up study of infantile psychosis. II. Social and behavioural outcome.

1 reference

12 December 2020

Use of citalopram in pervasive developmental disorders

1 reference

12 December 2020

Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium

1 reference

12 December 2020

A randomised, controlled study of dietary intervention in autistic syndromes

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism.

1 reference

12 December 2020

Repetitive thoughts and behavior in pervasive developmental disorders: treatment with serotonin reuptake inhibitors.

1 reference

12 December 2020

Effects of pyridoxine and magnesium on autistic symptoms--initial observations

1 reference

12 December 2020

Critique of "Efficacy of vitamin B6 and magnesium in the treatment of autism".

1 reference

12 December 2020

Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.

1 reference

12 December 2020

Multisite, double-blind, placebo-controlled trial of porcine secretin in autism

1 reference

12 December 2020

Use of methylphenidate in the treatment of children with autistic disorder.

1 reference

12 December 2020

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

12 December 2020

Risperidone in children with autism and serious behavioral problems

1 reference

12 December 2020

The incidence of seizures among children with autistic symptoms

1 reference

12 December 2020

1 reference

12 December 2020

Brief report: a double-blind study of naltrexone in infantile autism

1 reference

12 December 2020

Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism

1 reference

12 December 2020

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

12 December 2020

High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study

1 reference

12 December 2020

An open trial of risperidone in young autistic children.

1 reference

12 December 2020

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder

1 reference

12 December 2020

Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes

1 reference

12 December 2020

Risperidone and explosive aggressive autism

1 reference

12 December 2020

Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up.

1 reference

12 December 2020

Resolved: autistic children should have a trial of naltrexone.

1 reference

12 December 2020

10.2165/00023210-200519110-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference